Wednesday, March 12, 2025 3/12/2025

Rapid diagnostic tests for adenovirus conjunctivitis in children: An epidemiologic, clinical, and cost-effectiveness evaluation

Award Number: K23HD099925
ORGANIZATION: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

Group Awards By:

View Award Abstract

PROJECT SUMMARY/ABSTRACT Acute infectious conjunctivitis is one of the most common pediatric infections worldwide, however, the microbial causes of this infection are poorly understood. Though it has been estimated that up to 90% of conjunctivitis in children is viral in origin, over 80% of children with acute conjunctivitis are prescribed an ophthalmic antibiotic. This is a concern because incidence of antimicrobial resistant conjunctivitis is increasing, 8% of children have an adverse reaction to ophthalmic antibiotics, and prescription of ophthalmic antibiotics results in a large health care and social economic burden. Recently, an FDA approved point-of-care rapid antigen detection test for adenovirus conjunctivitis has become available. The test is $10.50, non-invasive, and can be completed in less than 15 minutes in the clinic setting. Implementation of this test may substantially reduce the use of ophthalmic antibiotics in children. The current utility of this test is limited, however, because: (1) data evaluating viral and bacterial causes of conjunctivitis in this age group are lacking; (2) rates of bacterial and viral concurrent infections are unknown; (3) the clinical sensitivity and specificity of the rapid point of care adenovirus test in children has not been assessed; and (4) cost effectiveness analysis for wide spread implementation of the test in pediatric settings has not been conducted. This proposal aims to meet the critical need to improve clinical care for children with conjunctivitis by (1) determining the viral and bacterial causes of conjunctivitis children; (2) clinically validating a rapid point of care adenovirus conjunctivitis test in children; and (3) estimating the percent reduction in unnecessary antibiotic prescriptions and cost-effectiveness of implementation of rapid adenovirus conjunctivitis diagnostic tests across health care systems. This project is the culmination of this candidate’s interest and experience in the validation and use of rapid infectious disease diagnostic tests to improve clinical care for children. The objective of this career development award is to develop this candidate into an independent principal investigator in clinical and translational research with expertise in the implementation and evaluation of infectious disease diagnostics in pediatrics. Mentorship, didactic coursework, seminars, and completion of the proposed study will address specific training needs of the investigator including training in the design and conduct of large-scale, multi-center clinical trials, advanced biostatistical analysis, and cost-effectiveness analysis. The candidate has assembled a multidisciplinary team of mentors and advisors with extensive research experience and topical expertise in the above realms to ensure her success in achieving the stated specific aims and career goals.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$10,576 )
2025	2023	DENVER HEALTH AND HOSPITAL AUTHORITY	777 BANNOCK ST	DENVER	CO	80204	DENVER	USA	Child Health and Human Development Extramural Research	000	5	11/19/2024	NON-COMPETING CONTINUATION	-$10,576
														Subtotal = -$10,576

Issue Date FY: 2023 ( Subtotal = $152,399 )
2023	2023	DENVER HEALTH AND HOSPITALS AUTHORITY	777 BANNOCK ST	DENVER	CO	80204	DENVER	USA	Child Health and Human Development Extramural Research	000	5	6/27/2023	NON-COMPETING CONTINUATION	$152,399
														Subtotal = $152,399

Issue Date FY: 2022 ( Subtotal = $152,399 )
2022	2022	DENVER HEALTH AND HOSPITALS AUTHORITY	777 BANNOCK ST	DENVER	CO	80204	DENVER	USA	Child Health and Human Development Extramural Research	000	4	6/16/2022	NON-COMPETING CONTINUATION	$152,399
														Subtotal = $152,399

Issue Date FY: 2021 ( Subtotal = $152,399 )
2021	2021	DENVER HEALTH AND HOSPITALS AUTHORITY	777 BANNOCK ST	DENVER	CO	80204	DENVER	USA	Child Health and Human Development Extramural Research	000	3	6/26/2021	NON-COMPETING CONTINUATION	$152,399
														Subtotal = $152,399

Issue Date FY: 2020 ( Subtotal = $152,399 )
2020	2020	DENVER HEALTH AND HOSPITALS AUTHORITY	777 BANNOCK ST	DENVER	CO	80204	DENVER	USA	Child Health and Human Development Extramural Research	000	2	5/11/2020	NON-COMPETING CONTINUATION	$152,399
														Subtotal = $152,399

Issue Date FY: 2019 ( Subtotal = $152,399 )
2019	2019	DENVER HEALTH AND HOSPITALS AUTHORITY	777 BANNOCK ST	DENVER	CO	80204	DENVER	USA	Child Health and Human Development Extramural Research	000	1	7/8/2019	NEW	$152,399
														Subtotal = $152,399

Grand Total All Awards = $751,419

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Rapid diagnostic tests for adenovirus conjunctivitis in children: An epidemiologic, clinical, and cost-effectiveness evaluation

Award Number: K23HD099925

ORGANIZATION: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer